Top Qs
Timeline
Chat
Perspective
4-Hydroxy-3-methoxymethcathinone
Pharmaceutical compound From Wikipedia, the free encyclopedia
Remove ads
4-Hydroxy-3-methoxymethcathinone (HMMC), or 3-methoxy-4-hydroxy-N-methylcathinone, is a monoamine releasing agent of the amphetamine and cathinone families.[1][2][3] It is an active metabolite of methylone (3,4-methylenedioxymethcathinone; MDMC).[1][2][3] The drug is a very low-potency serotonin–norepinephrine–dopamine releasing agent (SNDRA), with EC50 values of 7,210 nM for serotonin, 6,340 nM for norepinephrine, and 5,840 nM for dopamine in rat brain synaptosomes.[1][2] HMMC was first described in the scientific literature by 2011.[3][1][2]
Remove ads
See also
- 3,4-Dihydroxymethcathinone (HHMC; 3,4-DHMC)
- 4-Hydroxy-3-methoxyamphetamine (HMA)
- 4-Hydroxy-3-methoxymethamphetamine (HMMA)
- α-Methyldopamine (3,4-dihydroxyamphetamine; HHA; 3,4-DHA)
- α-Methylepinine (3,4-dihydroxymethamphetamine; HHMA, 3,4-DHMA)
References
External links
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads